Digestive & Intestinal Remedies (Pharmacies) - United Kingdom

United Kingdom

Highlights

Revenue in the Digestives & Intestinal Remedies market is projected to reach US$281.40m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 4.32%, resulting in a market volume of US$347.70m by 2029.
In global comparison, most revenue will be generated China (US$3.37bn in 2024).
In relation to total population figures, per person revenues of US$4.14 are generated in 2024.

Key regions:

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

The Digestive & Intestinal Remedies (Pharmacies) market in United Kingdom has been experiencing steady growth in recent years.

Customer preferences: Customers in the United Kingdom have shown a growing preference for digestive and intestinal remedies that are natural and organic. This shift in preference can be attributed to the increasing awareness and importance placed on overall health and wellness. Consumers are seeking products that are free from artificial ingredients and chemicals, and are instead opting for remedies that are made from natural ingredients. Additionally, there is a growing demand for digestive and intestinal remedies that are easy to consume, such as chewable tablets or liquid formulations.

Trends in the market: One of the key trends in the Digestive & Intestinal Remedies (Pharmacies) market in United Kingdom is the rise in online sales. With the increasing popularity of e-commerce platforms, more and more consumers are choosing to purchase their healthcare products online. This trend is driven by the convenience and accessibility that online shopping offers. Consumers can easily compare prices, read reviews, and make informed decisions from the comfort of their own homes. As a result, online retailers are gaining a larger share of the market. Another trend in the market is the growing demand for probiotic products. Probiotics are known to promote gut health and improve digestion. Consumers in the United Kingdom are becoming more aware of the benefits of probiotics and are actively seeking out products that contain these beneficial bacteria. This trend is driven by the increasing focus on preventive healthcare and the desire to maintain a healthy gut microbiome.

Local special circumstances: The Digestive & Intestinal Remedies (Pharmacies) market in United Kingdom is influenced by the country's aging population. As the population ages, there is a higher prevalence of digestive and intestinal issues such as indigestion, constipation, and irritable bowel syndrome. This has led to an increased demand for remedies that can alleviate these symptoms and improve overall digestive health. Additionally, the United Kingdom has a high prevalence of gastrointestinal diseases such as Crohn's disease and ulcerative colitis, which further drives the demand for digestive and intestinal remedies.

Underlying macroeconomic factors: The growth of the Digestive & Intestinal Remedies (Pharmacies) market in United Kingdom is also influenced by macroeconomic factors. The country's strong economy and high disposable income levels have contributed to increased consumer spending on healthcare products. Additionally, the National Health Service (NHS) in the United Kingdom provides free healthcare services, but there are limitations on the availability of certain medications and treatments. As a result, consumers often turn to over-the-counter remedies available at pharmacies to address their digestive and intestinal issues. In conclusion, the Digestive & Intestinal Remedies (Pharmacies) market in United Kingdom is witnessing growth due to the increasing preference for natural and organic remedies, the rise in online sales, and the growing demand for probiotic products. The country's aging population and high prevalence of gastrointestinal diseases also contribute to the market's development. The strong economy and high disposable income levels in United Kingdom further support the growth of the market.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.